chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up the next morning around 4am itching all over and started breaking out in red spots all over my body .  This has not lessened, but has become worse over time.  My eyes are swollen, I'm still itching all over and breaking out in hives.
Information has been received from a physician concerning an 8 year old patient who on 04-JAN-1999 was vaccinated with a 0.5 ml dose of Varivax (Lot# 627333/1244H). On 13-OCT-2006 the patient experienced breakthrough chickenpox. It was reported that skin lesions were cultured, varicella zoster was isolated and was identified by immuno-fluorescence. Subsequently, the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information is not expected.
This case was reported by a consumer via call center representative and described the occurrence of chills in a 66-year-old female patient who received Shingles vaccine for prophylaxis. On 23rd January 2019, the patient received the 2nd dose of Shingles vaccine. In January 2019, less than a day after receiving Shingles vaccine, the patient experienced chills, fever, headache, diarrhea and nausea. On an unknown date, the outcome of the chills, fever, headache, diarrhea and nausea were unknown. It was unknown if the reporter considered the chills, fever, headache, diarrhea and nausea to be related to Shingles vaccine. Additional details were reported as follows: The patient had all the adverse reactions from the Shingles shot that she got the day before reporting in the afternoon. The patient asked how long would these symptoms last.
I woke up the next morning after receiving the vaccine, feeling like someone had spent the entire night beating me with a baseball bat from the waist up. I am no stranger to pain having had my back broken in 3 places in my past. This was worse than that. I had a headache, extreme muscle soreness and joint pain, fatigue, the classic sore arm which is no big deal. I couldn't breathe. My lungs felt waterlogged and heavy, and my breathing made a whistle sound on the way in and on the way out. I was short of breath to the point that I took 3 Covid-19 tests that week, thinking I must have picked up covid on way to get the vaccine. ALL COVID-19 TESTS were NEGATIVE and have been negative since. However, the only thing that broke the worst of the breathing was taking a steroid inhaler that I had had from a GI Dr to be part of my treatment for temporary EOE (esophagus).  The inhaler helped and I used it as directed for a few days once all my covid tests came back negative. Though that saved me from the acute severe breathing difficulty, I have had lung trouble since. My lungs are still congested and I have a productive cough, constantly clearing what's in my lungs. I have been examined several times and do not have any illnesses or sicknesses that would be causing this like asthma or an infection. I wish I could go back in time and take the Pfizer vaccine instead. Though I shouldn't have to say this, I am pro-vaccine completely, but I feel like this second moderna shot has ruined my lungs. And this after being so careful NOT to contract Covid-19 so that I wouldn't have these kinds of long-term effects.
About 8:30 pm I started to feel very hot and flushed, itchy eyes and throat, lightheadedness. I took 650 mg Tylenol and went to sleep. I woke up at 3:30 am with very swollen eyes (almost swollen shut), swollen nose and upper lip about 3x normal size. Immediately took ibuprofen 600mg, Tylenol 650 mg and Zyrtec 10mg (I did not have Benadryl at home). Swelling resolved around 10:30 - 11 am. I never did have trouble breathing.
Patient received 2nd. dose of Pfizer on 8/26/21, only about 3.5 months out. No adverse effects currently from #3 dose.
Vomited; a rash in her vagina area; Vaginal itching; she scratched so much that got abrasions; Chest was red; heart rate was elevated; Eyes were swollen; She scratched so much that she got abrasions; Felt like she was having an anxiety attack; Her arms and legs were itchy/body overall was itchy; Chest felt tight; Allergic reaction; Swelling of her throat; Dose was administered on day 57; Nausea; Strong headache/head hurt; A spontaneous report was received from a consumer, a 36 year-old, female  patient who received Moderna's COVID-19 vaccine (mRNA-1273) 57 days after receiving first dose and developed an allergic reaction with generalized itching, swollen eyes, skin abrasions, throat swelling, chest tightness, chest erythema, elevated heart rate, nausea, vomiting, headache, anxiety attack and vaginal/vulvar rash.   The patient's medical history include severe allergies NOS.  Concomitant product included Benadryl prior to the second dose of the vaccine.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided).   On 22-Feb-2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number: 011M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 22-Feb-2021 , immediately after receiving vaccine, the patient experienced an allergic reaction with generalized itching, swollen eyes, skin abrasions, throat swelling, chest tightness, chest erythema, elevated heart rate, nausea, vomiting, headache, anxiety attack and vaginal/vulvar rash.  Treatment for the events included Phenergan, IV antihistamine, IV steroids, prednisone, hydroxyzine hydrochloride and EpiPen.    The patient received both scheduled doses of mRNA-1273 prior to the event, therefore, action taken with the drug in response to the event is not applicable.  The outcome of the events, allergic reaction with generalized itching, swollen eyes, skin abrasions, throat swelling, chest tightness, chest erythema, elevated heart rate, nausea, vomiting, headache, anxiety attack and vaginal/vulvar rash, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Patient's prior severe allergy history may have been contributory for the occurrence of the allergic reaction and associated events. Additionally, This report refers to a case of  an inappropriate schedule of product administration for mRNA-1273, lot #011M20A.
Eight days following my first dose of the Moderna covid vaccine, I developed a rash at the injection site.  It was red, hot, raised and extremely itchy.  It covered an area about 2.5" x 2.5 ".  Within 5 days, it was completely gone.
DTaP vaccination administered on 4/25/18, she cried and screamed immediately after injection, then was soothed for 10 mins or so, resumed crying for 20-30 mins until she feel asleep in the car, she slept an additional two naps that day, fever of 103 developed that night and lasted for 2 days, on 4/26/18 her lower body (legs and feet) swelled and developed a rash and she became ill with severe cold like symptoms, she would not sleep that night, crying on and off through the following day, rash slowly progressed into eczema on her legs and feet, the rash is very uncomfortable and she scratches it until it bleeds during the day and night, mucus the rash/eczema.
I had vaccination prior to noon on Feb 9, that afternoon I exhibited signs such as labored breathing, exhaustion. The next day I was not alert, that night Feb 10, just before midnight I had a grand mal seizure . The ambulance and police were at my  home a little after midnight.  They took me to Essentia hospital emergency room.  I was there for observation for several hours.  I notified my VA doctor about what happened, he scheduled a brain scan. nothing showed that would indicate a medical brain issue. Subsequently; I lost my driving privileges completely for several months and currently am driving on a limited license, which is normal in the case of a seizure in our state. See continuation page:
Constant headaches. Stroke like symptoms not being able to remember most everything. Can't do mu day to day job. Trouble reading and understanding.  Full body twitches.
Feeling of "unsettled " "anxious " feeling of doom " "depressed". Sore arm
Red, swollen skin lesion as big as an adult palm size with white patches in the middle.
Recipient received COVID-10 Vaccine Moderna at the age of 17 years & 6 months.  Recipient did not meet the age criteria for the vaccination product.
Vomitting, Fever, Sweats, abdominal pain, and light headness.
C/O swelling, itching, pain and redness to (R) arm. Massaged with ice and given acetaminophen.
Intended to administer ADULT PFIZER BIVALENT BOOSTER, instead administered ADULT PFIZER MONOVALENT gray cap.  Patient on 1/6 stated feeling great, with the arm feeling a little sore. Denies anything unusual.
Legal Issue Involved - AE sent to Legal Caller is a Merck employee reporting an AE for ROTATEQ that she received on 8/5/2022 via email. Caller states the email was sent from a consumer who stated his daughter received; This spontaneous report was received from the patient's mother via company representative on an email, referring to a female patient of unknown age. The patient's medical history, current conditions, concomitant therapies, and previous drugs reactions or allergies were not reported.  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally for prophylaxis (strength, dose, vaccination scheme, lot #, and expiry date were not provided).  On an unknown date, the patient develop an adverse reaction that almost killed her, and due to that adverse reaction she had to have an emergency surgery to saved her life. At the reporting time, the outcome of the event was not provided.  The causality assessment between the adverse reaction and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was reported as related.  Upon, an internal review the adverse reaction was determined to be medically significant.
This spontaneous report was received from a physician via a company representative refers to a female patient of over 70 years of age. The patient was reported to be relatively healthy without any relevant medical history. Approximately on an unknown date in 2013, reported as about two years ago, the patient was vaccinated with ZOSTAVAX (dose, route and lot number were not reported). There were no concomitant medications reported. On an unknown date in October 2014, reported as about 3 months ago, the patient experienced a mild case of shingles. The patient was treated with acyclovir for the event. The patient sought medical attention by calling the physician's office for her symptoms. There was no product quality complaint reported. The outcome of mild case of shingles was unknown. The causality of the event was not provided. Additional information is not expected, because there was no consent to follow up with the physician.
No patients experienced any adverse effects; Improperly stored dose of ROTATEQ; This spontaneous report was received from a physician concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, or drug reactions/allergies.     On 14-MAY-2020, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) vial (product storage error), by oral route (lot # 1660693, has been verified to be a valid lot number; expiration date 19-MAR-2021) as prophylaxis (dosage schedule and strength were not reported).   The administered dose of the vaccine experienced a multiple temperature excursions below highest temperature above 47 Fahrenheit degrees  to 66.6 Fahrenheit degrees for 2 hours and lowest temperature below 36 Fahrenheit degrees to 33.6 Fahrenheit degrees  for 45 minutes as recorded by a data logger. There was no previous temperature excursion. There was no adverse effect reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2006USA001703:
After injection of vaccines, patient had redness at all sites. IPV site was the largest. Redness developed within 2-3 minutes, no trouble breathing. Benadryl po given and patient (+mom) stated in clinic 20 minutes. Redness decreased . * Previous injections DTaP, Hib, IPV and PCV given 11/8/04: had redness and Benadryl given. Went away per mom: no problems
No Adverse event; Customer called in to report that they gave 2 children the 6mo-2yr vaccine dose 2 months past expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Customer called in to report that they gave 2 children the 6mo-2yr vaccine dose 2 months past expiration) and NO ADVERSE EVENT (No Adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 214K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-May-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 02-May-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Customer called in to report that they gave 2 children the 6mo-2yr vaccine dose 2 months past expiration). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Customer called in to report that they gave 2 children the 6mo-2yr vaccine dose 2 months past expiration) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Customer called in to report that they gave 2 children the 6mo-2yr vaccine dose 2 months past expiration).    No concomitant medication was reported.  No treatment medication was reported.  This case was reported for patient 2 out of 2 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-734150 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-734150:Patient 01
After the vaccine, I had regular symptoms from virus that you hear people talk about.  Head aches, muscle ache and soreness, then I felt better after a few days.  Off and on I would have good days and then I would have bad days.  I felt sluggish, and would make myself get through the day.  Some days I would have headaches and others not so much until month of May following the vaccine.   My head hurt almost every day, I was in a busy time in my family owned business as well.   I made an appointment with the Doctor and of course had to wait 2 weeks to get in.  I couldn't stand it any more and my wife got me in to see Dr. at the walk in clinic.  My Blood pressure was high, he did blood work and called and admitted me to hospital.  My numbers where all messed up and they told me my kidneys where not filtering. After 3 days at Hospital I was transfered to another hospital.  There I met a Nephrologist, who did test, biopsy on my kidneys and started me on dialysis.  My Biopsy report is as follows: 1 advanced Glomerular and tubulointerstital fibrosis (Approx. 60%) 2 Focal segemental glomerular sclerosing pattern, likely secondary 3 Moderate arteriolosclerosis 4 Rare neutrophil cast, superimposed pyelonephritis can not be excluded 5 active cellular cresents are not identified in light microscopic material. This basically says that the high blood pressure is what damaged my kidneys.  I went from a healthy 48 year old with no blood pressure issues, no health issues  until I took the vaccine and with in 6 months it killed the filtration of my kidneys.  I am now on dialysis 3 days a week and on the transplant list awaiting a new kidney.
he felt weakness; fever/100.1 degrees; chills; nausea; tiredness; headache; This is a spontaneous report from a contactable consumer (patient himself). A 25-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), via an unspecified route of administration at site of left arm (reported left shoulder) at 11:00 on 22Dec2020 at single dose for COVID-19 immunization. Before vaccination, patient was recently COVID-19 positive by a nasal swab COVID-19 test and had ended his quarantine period a few days before receiving the COVID-19 vaccine. There were no concomitant medications. After vaccination, he had chills, fever, nausea, tiredness, and headache around 10:00 PM on 22Dec2020, and throughout today, he had been experiencing these side effects. The side effects all hit at once. He felt weakness this morning on 23Dec2020, and then had a severe headache and chills. He had a headache and fever of 100.1 degrees. he had taken a generic dextromethorphan hydrobromide guaifenesin paracetamol pseudoephedrine hydrochloride (DAYQUIL, liqui-gels for his symptoms. and about 30 minutes later, his symptoms dissipated, and he was good for 3 hours until the symptoms came back. The outcome of event 'felt weakness' was unknown, of rest events was not recovered.
101 fever. Dizzy and light headed. Chills. Sweating. Migraine. Weak. Tired. Body aches   Last about 30 hours.
Bruising, soreness and red spot at injection site day after immunization (Friday, Nov. 16th). On Saturday, Nov. 17th, red spot spread to 2 1/2 inches in diameter just below injection site.
Left femoral DVT on 4/18/21. symptoms of left leg swelling noted on 4/18/21.
REDNESS, HOT, RASH APPEARANCE AND SWELLING, WAS GIVEN ANTI-BIOTIC.
Delayed reaction; Somnolence; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Delayed reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed reaction). At the time of the report, VACCINATION COMPLICATION (Delayed reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: Follow up received on 22-Apr-2021 included no new information. On 22-Apr-2021: Followup was  received on  22 April 2021. Reporter's last name from Patch to Hatch was added.Follow up received on 22-Apr-2021 included no new information.
Caller states he doesn't want to make other people sick and right now he is in quarantine since he does not know if he has COVID-19 or not.; right now he is in quarantine since he does not know if he has COVID-19 or not; fever; headache; cold; his body hurts; lungs hurt; eyes hurt; sore throat; Caller states before with the first and second shot he got no symptoms except a sore arm; This is a spontaneous report from a contactable consumer (patient). A 42-years-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration on 27Apr2021 as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The vaccination facility explained he may have some symptoms over the next couple of days be did not have any. The patient began having symptoms two days ago which was three weeks later from his second dose. The patient would like to know since he has received both doses and experiencing side effects that include fever, headache and a cold can he take medication for it or does he need to go to a doctor. His body hurts, lungs hurt, eyes hurt and he has a sore throat too. Yesterday he brought alka-seltzer plus cold and flu and it didn't help as he was still sore today. Today he has not had a fever but he had a fever yesterday and the day before. Before with the first and second shot he got no symptoms except a sore arm. The patient would like to know if he can go outside. He doesn't want to make other people sick and right now he was in quarantine since he does not know if he has COVID-19 or not. He was not going to work right now either. The patient received treatment for events. Outcome of the event was unknown.  Follow-up attempts completed. No further information is expected.
The patient received first dose of Rabipur on 21-Dec-2021 and no additional doses since then; Case reference number US-BN-2023-000274 is a spontaneous case report initially received from a nurse via Communication (reference number: USBAV23-0257) on 14-Feb-2023 and concerns an elderly female patient born in 1943.  The patient's relevant medical history and concomitant medication details were not provided.  On 01-Dec-2021, the patient was vaccinated with the first dose of RabAvert (batch number: ARBA911C), administered intramuscularly at a dose of 1 mL, at an unknown site of administration for pre-exposure rabies, and didn't receive any additional doses since then (explicitly coded as 'incomplete course of vaccination').  At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert.  Additional information received on 14-Feb-2023 included local case ID.; Reporter's Comments: An elderly female patient born in 1943 was vaccinated with the first dose of RabAvert in Dec-2021, administered intramuscularly at a dose of 1 mL, at an unknown site of administration for pre-exposure rabies, and didn't receive any additional doses since then, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to RabAvert, but to a human factor. The case is non-serious.; Sender's Comments: An elderly female patient born in 1943 was vaccinated with the first dose of RabAvert in Dec-2021, administered intramuscularly at a dose of 1 mL, at an unknown site of administration for pre-exposure rabies, and didn't receive any additional doses since then, which is considered as incomplete course of vaccination. No associated adverse events were reported. Incomplete course of vaccination is listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to RabAvert, but to a human factor. The case is non-serious.
Patient up to date on COVID vaccines who tested detected for COVID during her stay.  Patients spouse had been visiting and called to report positive test.  Patient with sore throat at time. Received Remdesivir.  No hypoxia noted.  Asymptomatic at time of d/c.
Severe hair loss, severe rashes.  Extreme scaling on scalp.  Unbearable itching.  Scalp flaking. Over 30% hair loss. Still losing.